For immunochemical detection of PPAD
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

PPAD (Porphyromonas gingivalis) Polyclonal Antibody

Item No. 37598

Technical Information
Synonyms
  • P. gingivalis Peptidylarginine Deiminase
Immunogen
Recombinant PPAD (P. gingivalis)
MW
~62 kDa (expected)
500 µg of protein A-purified polyclonal antibody
Storage Buffer
PBS, pH 7.2, containing 50% glycerol and 0.02% sodium azide
Host
Rabbit
Applications
ELISA, FC, IF, WB
Cross Reactivity
(+) PPAD(-) Human PAD2(-) PAD3(-) PAD4(-) PAD6
Species Reactivity
(+) P. gingivalis
UniProt Accession №
Q9RQJ2
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Porphyromonas gingivalis (P. gingivalis) peptidyl arginine deiminase (PPAD) is a bacterial enzyme and virulence factor secreted by P. gingivalis, an oral bacterium involved in the progression of periodontal disease.1,2 It is composed of a pro-peptide sequence, a catalytic domain, an immunoglobulin-like (Ig-like) domain, and a C-terminal domain, but the mature protein contains only the catalytic domain and Ig-like domain.2 It is expressed on the bacterial outer membrane. PPAD and proteolytic enzymes, such as arginine gingipain (RgpB), are released from P. gingivalis to break down proteins, which it uses as an energy source.1,2 RgpB cleaves proteins at arginine residues, and PPAD specifically deiminates the resulting C-terminal arginine residues of both bacterial and host proteins to citrulline, a process known as citrullination.1,3,2 Unlike mammalian PADs, PPAD does not require calcium and can convert free L-arginine into L-citrulline in addition to deaminating these residues at the C-terminus of proteins and peptides.4 A ppad deletion mutation (Δ8820) in P. gingivalis strain 381 increases biofilm formation, alters biofilm architecture, and induces the secretion of protein aggregates.1 Mice infected with a PPAD deficient strain of P. gingivalis have reduced periodontal inflammation and similarly infected mice in a model of collagen-induced arthritis have reduced bone erosion.5 Cayman’s PPAD (Porphyromonas gingivalis) Polyclonal Antibody can be used for ELISA, flow cytometry (FC), immunofluorescence (IF), and Western blot (WB) applications. The expected WB detection size is approximately 62 kDa from P. gingivalis samples.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Vermilyea, D.M., Ottenberg, G.K., and Davey, M.E. Citrullination mediated by PPAD constrains biofilm formation in P. gingivalis strain 381. NPJ Biofilms Microbiomes 5(1), 7 (2019).

    2. Montgomery, A.B., Kopec, J., Shrestha, L., et alCrystal structure of Porphyromonas gingivalis peptidylarginine deiminase: Implications for autoimmunity in rheumatoid arthritis. Ann. Rheum. Dis. 75(6), 1255-1261 (2016).

    3. Olsen, I., Singhrao, S.K., and Potempa, J. Citrullination as a plausible link to periodontitis, rheumatoid arthritis, atherosclerosis and Alzheimer’s disease. J. Oral Microbiol. 10(1), 1487742 (2018).

    4. Gómez-Bañuelos, E., Mukherjee, A., Darrah, E., et alRheumatoid arthritis-associated mechanisms of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. J. Clin. Med. 8(9), 1309 (2019).

    5. Gully, N., Bright, R., Marino, V., et alPorphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis. PLoS One 9(6), e100838 (2014).